Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 255-982-5 | CAS number: 42872-30-0
Skin irritation / corrosion
Administrative data
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Consistent test but without details of documents and no indication of GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 011
- Report date:
- 2011
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: Episkin: reconstructed human epidermis
- GLP compliance:
- no
Test material
- Reference substance name:
- 2-(m-benzoylphenyl)propionitrile
- EC Number:
- 255-982-5
- EC Name:
- 2-(m-benzoylphenyl)propionitrile
- Cas Number:
- 42872-30-0
- Molecular formula:
- C16H13NO
- IUPAC Name:
- 2-(3-benzoylphenyl)propanenitrile
- Details on test material:
- Test article: BPPN, an intermediate product of Ketoprofen synthesis
Batch: BPPN-E630
Constituent 1
Results and discussion
In vitro
Results
- Irritation / corrosion parameter:
- other: Not available
- Vehicle controls validity:
- not specified
- Negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Remarks on result:
- no indication of irritation
Any other information on results incl. tables
No data
Applicant's summary and conclusion
- Interpretation of results:
- not irritating
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- BPPN (batch BPPN-E630), an intermediate product of Ketorpofen synthesis, was non-irritant to the skin. It does not require labeling with any classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
